← All trials
NCT05190783
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2019
- Primary completion
- Aug 1, 2021
- Completion date
- Nov 1, 2021
- First posted
- Jan 13, 2022
- Last posted
- Jan 18, 2022
- Enrollment
- 60
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mansoura UniversityLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.